Other disclosed activity · PMVP
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Carulli MichaelChief Financial Officer |  PMVPPMV Pharmaceuticals, Inc.Grant or award | A | — 240.0K sh | Mar 9, 2026 traded Mar 5, 2026 |
Director · PMV Pharmaceuticals, Inc. · PMV Pharmaceuticals, Inc. — Stock Option (right to buy)
Grant or award — administrative, little informational value
No reported dollar value · new position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Carulli MichaelChief Financial Officer | PMVPPMV Pharmaceuticals, Inc. Grant or award | A | — 240.0K sh | Mar 9, 2026 traded Mar 5, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Eckler Matthew Joseph filed this Form 4 reporting a grant or award of PMVP on Oct 1, 2026. It became public on Oct 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.